Does skin care frequency affect the severity of incontinence-associated dermatitis in critically ill patients?

Abstract

The researchers studied a defined skin care protocol using a cleanser with aloe vera and a cleansing lotion, followed by application of either a moisture barrier with silicone or skin protectant with zinc oxide and menthol, undertaken at two different frequencies. Data revealed the incidence of moderate IAD was decreased in the experimental group (receiving the skin protocol every 6 hours and p.r.n.).

Use of Ozone to Treat Ileostomy Dermatitis in an Experimental Rat Model

“…Various topical agents other than zinc oxide have been used in the treatment of dermatitis, which is a significant complication of ileostomy. Sometimes it is not possible to cope with the location of the ileostomy; therefore, it becomes necessary to change the region of the ileostomy [ 7 , 23 , 24 ]. There have been multiple reports presenting the positive effects of ozone therapy in wound healing [ 15 , 17 , 25 ].…”

“…Eroded peristomal skin can be treated with a hydrocolloid powder before placing the stoma appliance. Topical and aerosol corticosteroids or antihistamines have been useful in speeding peristomal skin recovery [ 1 , 6 ], while zinc oxide has been used topically in irritant dermatitis treatment and is known for its treatment efficacy [ 7 – 12 ].…”

Incontinence‐associated dermatitis in the critically ill patient: an intensive care perspective

“…Eleven studies were identified that specifically addressed IAD in the adult critical care or ICU setting (Bliss et al, ; Bohnenkamp et al, ; Brunner et al, ; Conley et al, ; Coyer et al, ; Driver, ; Ehman et al, ; Eigsti, ; Ma et al, ; Park and Kim, ; Peterson et al, ). Of these 11 studies, 2 studies were published conference abstracts (Ehman et al, ; Peterson et al, ) and 1 study was a conference poster presentation (Bohnenkamp et al, ).…”

“…IAD is a common yet under‐reported phenomenon in the intensive care setting. Of the 11 studies identified, 3 reported IAD prevalence, with ranges from 61·5% to 95% (Bohnenkamp et al, ; Conley et al, ; Peterson et al, ), and one study reported incidence of 29% (Ma et al, ). Furthermore, six studies reported a pre‐intervention IAD incidence range of 23–50% (Bliss et al, ; Brunner et al, ; Coyer et al, ; Driver, ; Ehman et al, ).…”

“…Of the studies reviewed that clinically assessed IAD in the critical care setting, five used a self‐developed tool for the clinical assessment of IAD (Bohnenkamp et al, ; Brunner et al, ; Driver, ; Ehman et al, ; Eigsti, ), two studies used the perirectal skin assessment tool (PSAT) developed by Brown in 1993 (Bliss et al, ; Conley et al, ), one study used the IAD severity instrument (Park and Kim, ), and one study used the skin assessment tool by Kennedy and Lutz () (Coyer et al, ). It is notable that a variety of clinical assessment and severity categorisation tools are reported in the studies reviewed, but these are not used in daily clinical practice.…”